Physician profile
Jeff S Chen
NPI 1922202407
$2,989.25
in general payments reported to CMS, 2019-2025
22 companies · $15.60 in 2025
The $15.60 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $672 · 2021: $193 · 2022: $75.80 · 2023: $376 · 2024: $452 · 2025: $15.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,409.56 | 2019-2024 | Senza |
| Abbvie INC. | $204.42 | 2021-2024 | Ubrelvy, Botox |
| Collegium Pharmaceutical, INC. | $164.30 | 2019-2023 | Belbuca |
| Scilex Pharmaceuticals INC. | $154.04 | 2021-2025 | Ztlido |
| Pfizer INC. | $153.56 | 2019 | |
| Saluda Medical Americas, INC. | $152.80 | 2023 | Evoke Scs |
| Medtronic, INC. | $134.16 | 2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $88.71 | 2021 | |
| Daiichi Sankyo INC. | $80.81 | 2019 | |
| Coopervision INC. | $70.00 | 2023 | Misight Contact Lens |
| Covidien Lp | $54.02 | 2019 | |
| Spr Therapeutics, INC | $51.56 | 2019 | |
| Biodelivery Sciences International, INC. | $49.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.49 | 2019 | |
| Tersera Therapeutics LLC | $42.44 | 2020-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $27.58 | 2021 | |
| Bausch & Lomb Americas INC. | $24.41 | 2024 | Infuse, Biotrue |
| Fidia Pharma USA INC. | $19.39 | 2022 | |
| Nalu Medical, INC. | $17.70 | 2024 | Nalu Neurostimulation System |
| Astrazeneca Pharmaceuticals Lp | $17.50 | 2019 | |
| Abbott Laboratories | $16.44 | 2024 | Eterna |
| Bioventus LLC | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.